Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 111, Issue 2, 2000, Pages 608-617

  Shalhoub, V ^a   Elliott, G ^b   Chiu, L ^b   Manoukian, R ^b   Kelley, M ^b   Hawkins, N ^b   Davy, E ^b   Shimamoto, G ^a   Beck, J ^a   Kaufman, S A ^a   Van, G ^a   Scully, S ^a   Qi, M ^a   Grisanti, M ^a   Dunstan, C ^a   Boyle, W J ^b   Lacey, D L ^a  

^a AMGEN INC   (United States)

^b Department of Cell Biology ^*  (United States)

Author keywords

B CLL; Co stimulatory molecules; Cytokines; Natural immunity; T cells

Indexed keywords

B7 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SYNTHESIS; DOWN REGULATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD80; B-LYMPHOCYTES; CYTOKINES; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-2; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034530001     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02383.x     Document Type: Article

References (54)

1. Humoral immune response against p53 protein in patients with colorectal carcinoma
2. EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype
3. Separation of lymphocytes, lymphocyte sub-groups and monocytes: A review
4. Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast: Cancer cells in vitro
5. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: Stimulation of allogeneic versus autologous T cells generates different types of effector cells
6. Cytokines, chaos, and complexity
7. Co-stimulation in T cell responses
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Cytokine enhancement of immunogenicity in chronic myeloid leukaemia
10. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40
11. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells
12. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer
13. Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients
14. T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma
15. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors
16. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions
17. Real-time quantitative RT-PCR after laser-assisted cell picking
18. Chronic lymphocytic leukemia: New insights into biology and therapy
19. Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage
20. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia
21. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function
22. Real time quantitative PCR
23. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone
24. Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens
25. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells
26. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2- integrins), CD54 (1CAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia
27. Chronic lymphocytic leukemia
28. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood
29. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids
30. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma
31. HLA antigens in chronic lymphocytic leukemia
32. Molecular pathogenesis of chronic lymphocytic leukemia: Factors and signaling pathways regulating cell growth and survival
33. Mutational staus if IG VH genes profices clinically valuable information in B-cell chronic lymphocytic leukemia
34. Idiotype-specific T cells in multiple myeloma stage I: An evaluation by four different functional tests
35. Idiotype immunization combined with granulocyte-macrophage colony- stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8+ and CD4+specific T-cell responses
36. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR
37. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells
38. Clinical staging of chronic lymphocytic leukemia
39. Oligoclonal TCR BV gene usage in B cell chronic lymphocytic leukemia: Major perturbations are prefentially seen within the CD4 T cell subset
40. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia
41. Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulation
42. In vitro predictors of therapeutic response in melanoma patients receiving tumor infiltrating lymphocytes and interleukin-2
43. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia
44. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells
45. Induction of antigen-specific T and B cell immunity in colon carcinoma patients by anti-idiotypic antibody
46. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes
47. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene
48. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules
49. Functions of CD40 on B cells, dendritic cells and other cells
50. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells
51. T cells recognize the VH complementarity determining region 3 of the idiotypic protein of the B cell non-Hodgkin's lymphoma
52. Idiotype-induced T cell stimulation requires antigen presentation in association with HLA-DR molecules
53. Idiotype-specific T lymphocytes in monoclonal gammopathies: Evidence for the presence of CD4+ and CD8+ subsets